Showing results out of
The GSK Vaccines site in Siena hosted the annual EMBL in Italy event. The hybrid meeting brought together industry leaders, representatives from biotech start-ups, data scientists, and researchers from academia.
CONNECTIONS2022
alumniconnections
Scientists develop technology to measure how ATP concentration affects protein solubility in cells
SCIENCE & TECHNOLOGY2019
sciencescience-technology
Takeda joins pioneering public-private drug discover collaboration Open Targets
LAB MATTERSPEOPLE & PERSPECTIVES2017
lab-matterspeople-perspectives
Abel Ureta-Vidal and Louise Modis join colleagues and peers at gathering of UK-based alumni
CONNECTIONS2016
alumniconnections
Pioneering target validation collaboration expands to accelerate drug discovery research.
CONNECTIONSLAB MATTERS2016
connectionslab-matters
Identifying evidence-based relationships between drug targets and diseases.
CONNECTIONSLAB MATTERS2015
connectionslab-matters
Career insights from Riccardo Cortese, whose start-up is developing an Ebola vaccine candidate.
LAB MATTERS2015
alumnilab-matters
Alumni in senior positions in industry share career challenges, highlights and EMBL’s continuing role.
LAB MATTERS2015
alumnilab-matters
Jeffrey Barrett appointed Director of CTTV, the GSK, EMBL-EBI and Sanger Institute partnership.
LAB MATTERS2015
lab-matters
A new EMBL-EBI biomedical initiative works to determine the best target proteins for new drugs.
CONNECTIONSLAB MATTERS2014
connectionslab-matters
No results found